Chengdu Yacht Biotechnology is an API manufacturer. It holds 11 active US drug master files across a filed portfolio of 9 molecules.
| Molecule | Regulators | Docs |
|---|---|---|
| Daptomycin | US FDA | 2 |
| Everolimus | US FDA | 2 |
| Anidulafungin | US FDA | 1 |
| Caspofungin | US FDA | 1 |
| Dalbavancin | US FDA | 1 |
| Mupirocin | US FDA | 1 |
| Pimecrolimus | US FDA | 1 |
| Polymyxin B | US FDA | 1 |
| Tacrolimus | US FDA | 1 |
Also appears on these molecule pages
Choose your molecules and target markets. Chengdu Yacht Biotechnology comes back tiered against every other supplier able to file there.
Start for free